|
|
Daniela Cota, Giovanni Marsicano, Matthias Tschöp, Yvonne Grübler, Cornelia Flachskamm, Mirjam Schubert, Dorothee Auer, Alexander Yassouridis, Christa Thöne-Reineke, Sylvia Ortmann, Federica Tomassoni, Cristina Cervino, Enzo Nisoli, Astrid C.E. Linthorst, Renato Pasquali, Beat Lutz, Günter K. Stalla, Uberto Pagotto
J Clin Invest. 2003;
112(3):423
doi:10.1172/JCI17725
Abstract |
Full text
| PDF

T
he cannabinoid receptor type 1 (CB1) and its endogenous ligands, the endocannabinoids, are involved in the regulation of food intake. Here we show that the lack of CB1 in mice with a disrupted CB1 gene causes hypophagia and leanness. As compared with WT (CB1+/+) littermates, mice lacking CB1 (CB1–/–) exhibited reduced spontaneous caloric intake and, as a consequence of reduced total fat mass, decreased body weight. In young CB1–/– mice, the lean phenotype is predominantly caused by decreased caloric intake, whereas in adult CB1–/– mice, metabolic factors appear to contribute to the lean phenotype. No significant differences between genotypes were detected regarding locomotor activity, body temperature, or energy expenditure. Hypothalamic CB1 mRNA was found to be coexpressed with neuropeptides known to modulate food intake, such as corticotropin-releasing hormone (CRH), cocaine-amphetamine–regulated transcript (CART), melanin-concentrating hormone (MCH), and prepro-orexin, indicating a possible role for endocannabinoid receptors within central networks governing appetite. CB1–/– mice showed significantly increased CRH mRNA levels in the paraventricular nucleus and reduced CART mRNA levels in the dorsomedial and lateral hypothalamic areas. CB1 was also detected in epidydimal mouse adipocytes, and CB1-specific activation enhanced lipogenesis in primary adipocyte cultures. Our results indicate that the cannabinoid system is an essential endogenous regulator of energy homeostasis via central orexigenic as well as peripheral lipogenic mechanisms and might therefore represent a promising target to treat diseases characterized by impaired energy balance.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(123)
| Title and authors |
Publication |
Year |
The Central Cannabinoid CB1 Receptor Is Required for Diet-Induced Obesity and Rimonabant's Antiobesity Effects in Mice
Zhen Pang, Nancy N. Wu, Weiguang Zhao, David C. Chain, Erica Schaffer, Xin Zhang, Preeti Yamdagni, Vaseem A. Palejwala, Chunpeng Fan, Sarah G. Favara, Holly M. Dressler, Kyriakos D. Economides, Daniel Weinstock, Jean S. Cavallo, Souad Naimi, Anne-Marie Galzin, Etienne Guillot, Marie-Pierre Pruniaux, Michael J. Tocci, H. Greg Polites
|
Obesity
|
2011 |
Rimonabant Redux and Strategies to Improve the Future Outlook of CB1 Receptor Neutral-Antagonist/Inverse-Agonist Therapies
Sara Jane Ward, Robert B. Raffa
|
Obesity
|
2011 |
Rimonabant: From RIO to Ban
Amir H. Sam, Victoria Salem, Mohammad A. Ghatei
|
Journal of Obesity
|
2011 |
Large Size Cells in the Visceral Adipose Depot Predict Insulin Resistance in the Canine Model
Morvarid Kabir, Darko Stefanovski, Isabel R. Hsu, Malini Iyer, Orison O. Woolcott, Dan Zheng, Karyn J. Catalano, Jenny D. Chiu, Stella P. Kim, Lisa N. Harrison, Viorica Ionut, Maya Lottati, Richard N. Bergman, Joyce M. Richey
|
Obesity
|
2011 |
Efficacy and Safety of CP-945,598, a Selective Cannabinoid CB1 Receptor Antagonist, on Weight Loss and Maintenance
Louis J. Aronne, Nick Finer, Priscilla A. Hollander, Richard D. England, Solomon S. Klioze, Robert D. Chew, Robert J. Fountaine, Coralie M. Powell, John D. Obourn
|
Obesity
|
2011 |
Pharmacological treatment of obesity in children and adolescents: present and future.
Lorenzo Iughetti, Mariachiara China, Rossella Berri, Barbara Predieri
|
Journal of Obesity
|
2011 |
Induction of fatty acid oxidation resists weight gain, ameliorates hepatic steatosis and reduces cardiometabolic risk factors
R S Vijayakumar, Y Lin, K-S Shia, Y-N Yeh, W-P Hsieh, W-C Hsiao, C-P Chang, Y-S Chao, M-S Hung
|
Int J Obes Relat Metab Disord
|
2011 |
The CB1 Receptor Antagonist SR141716A Reverses Adult Male Mice Overweight and Metabolic Alterations Induced by Early Stress
Carina A. Valenzuela, Valeska A. Castillo, Carolina A. Aguirre, Ana M. Ronco, Miguel N. Llanos
|
Obesity
|
2010 |
The endocannabinoid system links gut microbiota to adipogenesis
Giulio G Muccioli, Damien Naslain, Fredrik Bäckhed, Christopher S Reigstad, Didier M Lambert, Nathalie M Delzenne, Patrice D Cani
|
Mol Syst Biol
|
2010 |
A clinical trial assessing the safety and efficacy of taranabant, a CB1R inverse agonist, in obese and overweight patients: a high-dose study
L J Aronne, S Tonstad, M Moreno, I Gantz, N Erondu, S Suryawanshi, C Molony, S Sieberts, J Nayee, A G Meehan, D Shapiro, S B Heymsfield, K D Kaufman, J M Amatruda
|
Int J Obes Relat Metab Disord
|
2010 |
|